福米西林 | 98048-07-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 福米西林
• 英文名称: Fomidacillin
• 英文别名: (2S,5R,6R)-6-[[(2R)-2-(3,4-dihydroxyphenyl)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]acetyl]amino]-6-formamido-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
• CAS: 98048-07-8
• 化学式: C₂₄H₂₈N₆O₁₀S
• 分子量: 592.6
• InChiKey: BLHZPPIRNRDRSC-HSDAMQNGSA-N

物化性质

• 密度：
  1.67±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  41
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  251
• 氢给体数：
  6
• 氢受体数：
  11

文献信息

• Carboxylic acid esters of pharmaceutical compounds
  申请人：Ascher Gerd

  公开号：US20060122164A1

  公开（公告）日：2006-06-08

  A pharmaceutically active compound having a carboxylic acid group —COOH as a part of its chemical structure which —COOH group is in the form of a carboxylic acid ester.

  一种具有羧酸基—COOH作为其化学结构的药物活性化合物，其中—COOH基团以羧酸酯的形式存在。
• Diagnostic/therapeutic agents
  申请人：Klaveness Jo

  公开号：US20050002865A1

  公开（公告）日：2005-01-06

  Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.

  可定位的诊断和/或治疗活性剂，例如超声对比剂，包括悬浮在水载体液中的报告物，该报告物包含含气体或生成气体的材料，该剂能够与目标形成至少两种结合对。
• THE ANTIBIOTICS COMPOSITION COMPRISING BETA-LACTAM ANTIBIOTICS AND BUFFERS
  申请人：Tianjin Hemey Bio-Tech Co., Ltd.

  公开号：EP2062582A1

  公开（公告）日：2009-05-27

  The antibiotics composition comprising at least one of beta-lactam antibiotics and buffers, further comprising at least one of beta-lactamase inhibitors. The composition can be formulated with at least one of aminoglycoside antibiotics into solution for controlling microbial infection in a container.

  由至少一种β-内酰胺类抗生素和缓冲剂组成的抗生素组合物，还包括至少一种β-内酰胺酶抑制剂。该组合物可与至少一种氨基糖苷类抗生素配制成溶液，用于控制容器中的微生物感染。
• THE ANTIBIOTICS COMPOSITION COMPRISING AMINOGLYCOSIDE ANTIBIOTICS
  申请人：Tianjin Hemey Bio-Tech Co., Ltd.

  公开号：EP2062585A1

  公开（公告）日：2009-05-27

  The antibiotics composition comprising at least one of aminoglycoside antibiotics and at least one of ionic chelating agents used for inhibiting particulate formation, or at least one of buffers, or at least one of ionic chelating agents and buffers simultaneously. The composition can be formulated into solution, or combined with at least one of beta-lactam antibiotics, or combined with at least one of beta-lactam antibiotics and at least one of beta-lactamase inhibitors into solutions for controlling microbial infection in a container.

  抗生素组合物包括至少一种氨基糖苷类抗生素和至少一种用于抑制微粒形成的离子螯合剂，或至少一种缓冲剂，或同时包括至少一种离子螯合剂和缓冲剂。该组合物可配制成溶液，或与β-内酰胺类抗生素中的至少一种结合，或与β-内酰胺类抗生素中的至少一种和β-内酰胺酶抑制剂中的至少一种结合成溶液，用于控制容器中的微生物感染。
• THE ANTIBIOTICS COMPOSITION COMPRISING BETA-LACTAM ANTIBIOTICS AND IONIC CHELATING AGENTS
  申请人：Tianjin Hemey Bio-Tech Co., Ltd.

  公开号：EP2062581A1

  公开（公告）日：2009-05-27

  The antibiotics composition comprising at least one of beta-lactam antibiotics and at least one of ionic chelating agents used for inhibiting particulate formation, further comprising at least one of beta-lactamase inhibitors or buffers, or at least one of beta-lactamase inhibitors and buffers simultaneously. The composition can be formulated with at least one of aminoglycoside antibiotics into solution for controlling microbial infection in a container.

  抗生素组合物，包括至少一种β-内酰胺类抗生素和至少一种用于抑制微粒形成的离子螯合剂，进一步包括至少一种β-内酰胺酶抑制剂或缓冲剂，或同时包括至少一种β-内酰胺酶抑制剂和缓冲剂。该组合物可与至少一种氨基糖苷类抗生素配制成溶液，用于控制容器中的微生物感染。